What's next? Rescue protocols for canine lymphoma - DVM
News Center
DVM Featuring Information from:


What's next? Rescue protocols for canine lymphoma


Dr. Cronin earned her DVM degree from Cornell University in 1990. She completed an internship at the Animal Medical Center in New York and a medical oncology residency at North Carolina State University. She is a diplomate of the American College of Veterinary Internal Medicine in the specialty of oncology. After completing her residency, she was lecturer at the University of Pennsylvania Veterinary Teaching Hospital and a medical oncologist at Angell Memorial Animal Hospital in Boston. In 2001, she co-founded the New England Veterinary Oncology Group in Waltham, Mass.


  • L'Heureux DA, Moore AS et al. Evaluation of a Discontinuous Protocol (VELCAP-S) for Canine Lymphoma. J Vet Intern Med 2001; 15:348-354.
  • Ogilvie GK, Berman PJ. Drug Resistance and Cancer Therapy. Compendium 1995; 17:549-556.
  • Page RL, Lee JJ et al. P-Glycoprotein Expression in Canine Lymphoma. Cancer 1996;77:1892-1898.
  • Leifer CE, Calvert CA. Doxorubicin for Treatment of Canine Lymphosarcoma After Development of Resistance to Combination Chemotherapy. JAVMA 1981;179:1011-1012.
  • Madewell BR, Lucroy MD et al. Evaluation of Single-Agent Mitoxantrone as Chemotherapy for Relapsing Canine Lymphoma. J Vet Inter Med 1998;12:325-329.
  • Mooney SC, Rassnick KM. MOPP chemotherapy for the treatment of resistant lymphoma in dogs: a retrospective study of 177 cases (1989-2000). J Vet Intern Med 2002;16:576-580.
  • Cuoto GC, Alvarez FJ et al. Dexamethasone, Melphalan, Actinomycin D, Cytosine Arabinoside (DMAC) Protocol for Dogs with Relapsed Lymphoma. J Vet Intern Med 2006;20:1178-1183.
  • Van Vechten M, Hefland SC. Treatment of Relapsed Canine Lymphoma with Doxorubicin and Dacarbazine. JVIM 1990; 4:187-191.
  • Laing EJ, Fitzpatrick PJ. Half-Body Radiation Therapy in the Treatment of Canine Lymphoma. J Vet Intern Med 1889: 3:102-108.


Source: DVM360 MAGAZINE,
Click here